Literature DB >> 19419954

Up-regulation of miR-21 by HER2/neu signaling promotes cell invasion.

Tzu-Hsuan Huang1, Fangting Wu, Gabriel B Loeb, Ruby Hsu, Amy Heidersbach, Allison Brincat, Dai Horiuchi, Robert J Lebbink, Yin-Yuan Mo, Andrei Goga, Michael T McManus.   

Abstract

The cell surface receptor tyrosine kinase HER2/neu enhances tumor metastasis. Recent studies suggest that deregulated microRNA (miRNA) expression promotes invasion and metastasis of cancer cells; we therefore explored the possibility that HER2/neu signaling induces the expression of specific miRNAs involved in this process. We identified a putative oncogenic miRNA, miR-21, whose expression is correlated with HER2/neu up-regulation and is functionally involved in HER2/neu-induced cell invasion. We show that miR-21 is up-regulated via the MAPK (ERK1/2) pathway upon stimulation of HER2/neu signaling in breast cancer cells, and overexpression of other ERK1/2 activators such as RASV12 or ID-1 is sufficient to induce miR-21 up-regulation in HER2/neu-negative breast cancer cells. Furthermore, the metastasis suppressor protein PDCD4 (programmed cell death 4) is down-regulated by miR-21 in breast cancer cells expressing HER2/neu. Our data reveal a mechanism for HER2/neu-induced cancer cell invasion via miRNA deregulation. In addition, our results identify miR-21 as a potential therapeutic target for the prevention of breast cancer invasion and metastasis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19419954      PMCID: PMC2709372          DOI: 10.1074/jbc.M109.006676

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  The transformation suppressor protein Pdcd4 shuttles between nucleus and cytoplasm and binds RNA.

Authors:  Maret Böhm; Kirsty Sawicka; Jan Peter Siebrasse; Anne Brehmer-Fastnacht; Reiner Peters; Karl-Heinz Klempnauer
Journal:  Oncogene       Date:  2003-07-31       Impact factor: 9.867

2.  Exploring the metabolic and genetic control of gene expression on a genomic scale.

Authors:  J L DeRisi; V R Iyer; P O Brown
Journal:  Science       Date:  1997-10-24       Impact factor: 47.728

3.  Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.

Authors:  D J Slamon; W Godolphin; L A Jones; J A Holt; S G Wong; D E Keith; W J Levin; S G Stuart; J Udove; A Ullrich
Journal:  Science       Date:  1989-05-12       Impact factor: 47.728

4.  Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities.

Authors:  M Tan; J Yao; D Yu
Journal:  Cancer Res       Date:  1997-03-15       Impact factor: 12.701

5.  Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor.

Authors:  A Migliaccio; D Piccolo; G Castoria; M Di Domenico; A Bilancio; M Lombardi; W Gong; M Beato; F Auricchio
Journal:  EMBO J       Date:  1998-04-01       Impact factor: 11.598

6.  Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease.

Authors:  C T Guy; M A Webster; M Schaller; T J Parsons; R D Cardiff; W J Muller
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

7.  Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasis.

Authors:  Sylvia Fong; Yoko Itahana; Tomoki Sumida; Jarnail Singh; Jean-Philippe Coppe; Yong Liu; Peter C Richards; James L Bennington; Nancy M Lee; Robert J Debs; Pierre-Yves Desprez
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-24       Impact factor: 11.205

8.  A novel pathway for mammary epithelial cell invasion induced by the helix-loop-helix protein Id-1.

Authors:  P Y Desprez; C Q Lin; N Thomasset; C J Sympson; M J Bissell; J Campisi
Journal:  Mol Cell Biol       Date:  1998-08       Impact factor: 4.272

9.  Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis.

Authors:  Yan M Li; Yong Pan; Yongkun Wei; Xiaoyun Cheng; Binhua P Zhou; Ming Tan; Xiaoyan Zhou; Weiya Xia; Gabriel N Hortobagyi; Dihua Yu; Mien-Chie Hung
Journal:  Cancer Cell       Date:  2004-11       Impact factor: 31.743

10.  HER2 expression in cervical cancer as a potential therapeutic target.

Authors:  Alma Chavez-Blanco; Victor Perez-Sanchez; Aurora Gonzalez-Fierro; Teresa Vela-Chavez; Myrna Candelaria; Lucely Cetina; Silvia Vidal; Alfonso Dueñas-Gonzalez
Journal:  BMC Cancer       Date:  2004-09-01       Impact factor: 4.430

View more
  88 in total

1.  Transcriptional regulation of the protocadherin β cluster during Her-2 protein-induced mammary tumorigenesis results from altered N-glycan branching.

Authors:  Huabei Guo; Alison Nairn; Mitche dela Rosa; Tamas Nagy; Shaying Zhao; Kelley Moremen; Michael Pierce
Journal:  J Biol Chem       Date:  2012-06-04       Impact factor: 5.157

2.  MicroRNA MIR21 and T Cells in Colorectal Cancer.

Authors:  Kosuke Mima; Reiko Nishihara; Jonathan A Nowak; Sun A Kim; Mingyang Song; Kentaro Inamura; Yasutaka Sukawa; Atsuhiro Masuda; Juhong Yang; Ruoxu Dou; Katsuhiko Nosho; Hideo Baba; Edward L Giovannucci; Michaela Bowden; Massimo Loda; Marios Giannakis; Adam J Bass; Glenn Dranoff; Gordon J Freeman; Andrew T Chan; Charles S Fuchs; Zhi Rong Qian; Shuji Ogino
Journal:  Cancer Immunol Res       Date:  2015-09-29       Impact factor: 11.151

3.  MicroRNA-21 promotes the proliferation and inhibits apoptosis in Eca109 via activating ERK1/2/MAPK pathway.

Authors:  Fengxia Liu; Shutao Zheng; Tao Liu; Qing Liu; Meng Liang; Xiuling Li; Ilyar Sheyhidin; Xiaomei Lu; Wenya Liu
Journal:  Mol Cell Biochem       Date:  2013-05-25       Impact factor: 3.396

Review 4.  Metastamirs: a stepping stone towards improved cancer management.

Authors:  Nicole M A White; Eman Fatoohi; Maged Metias; Klaus Jung; Carsten Stephan; George M Yousef
Journal:  Nat Rev Clin Oncol       Date:  2010-11-02       Impact factor: 66.675

Review 5.  microRNAs in cancer cell response to ionizing radiation.

Authors:  Jennifer R Czochor; Peter M Glazer
Journal:  Antioxid Redox Signal       Date:  2014-02-04       Impact factor: 8.401

6.  Pilot Study of Serum MicroRNA-21 as a Diagnostic and Prognostic Biomarker in Egyptian Breast Cancer Patients.

Authors:  Eman A Toraih; Eman A Mohammed; Sherif Farrag; Nevene Ramsis; Somaya Hosny
Journal:  Mol Diagn Ther       Date:  2015-06       Impact factor: 4.074

Review 7.  MicroRNA regulation of innate immune responses in epithelial cells.

Authors:  Rui Zhou; Steven P O'Hara; Xian-Ming Chen
Journal:  Cell Mol Immunol       Date:  2011-07-04       Impact factor: 11.530

8.  Antisense inhibition of microRNA-21 and microRNA-221 in tumor-initiating stem-like cells modulates tumorigenesis, metastasis, and chemotherapy resistance in pancreatic cancer.

Authors:  Yue Zhao; Lu Zhao; Ivan Ischenko; Qi Bao; Bettina Schwarz; Hanno Nieß; Yan Wang; Andrea Renner; Josef Mysliwietz; Karl-Walter Jauch; Peter J Nelson; Joachim W Ellwart; Christiane J Bruns; Peter Camaj
Journal:  Target Oncol       Date:  2015-02-03       Impact factor: 4.493

9.  High expression of miR-21 in triple-negative breast cancers was correlated with a poor prognosis and promoted tumor cell in vitro proliferation.

Authors:  Guizhi Dong; Xiaoling Liang; Deguang Wang; Huiquan Gao; Ling Wang; Lili Wang; Jingjun Liu; Zhaohui Du
Journal:  Med Oncol       Date:  2014-06-15       Impact factor: 3.064

10.  Heterogeneous nuclear ribonucleoprotein C1/C2 controls the metastatic potential of glioblastoma by regulating PDCD4.

Authors:  Young Mi Park; Su Jin Hwang; Kiyoshi Masuda; Kyung-Min Choi; Mi-Ran Jeong; Do-Hyun Nam; Myriam Gorospe; Hyeon Ho Kim
Journal:  Mol Cell Biol       Date:  2012-08-20       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.